NeurAxis, Inc. (NRXS)
NYSEAMERICAN: NRXS · Real-Time Price · USD
6.79
-0.22 (-3.14%)
Aug 5, 2026, 4:00 PM EDT - Market closed
NeurAxis Market Cap
NeurAxis has a market cap or net worth of $84.09 million as of August 5, 2026. Its market cap has increased by 250.26% in one year.
Market Cap
84.09M
Enterprise Value
77.36M
1-Year Change
250.26%
Ranking
Category
Stock Price
$6.79
ChartMarket Cap Chart
Since the IPO on August 9, 2023, NeurAxis's market cap has increased from $18.37M to $84.09M, an increase of 357.71%. That is a compound annual growth rate of 66.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 84.09M | 73.87% |
| Dec 31, 2025 | 48.36M | 194.84% |
| Dec 31, 2024 | 16.40M | 16.15% |
| Dec 29, 2023 | 14.12M | -23.13% |
| Aug 9, 2023 | 18.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Telomir Pharmaceuticals | 85.96M |
| Gossamer Bio | 85.35M |
| Biomea Fusion | 85.31M |
| Rallybio | 84.19M |
| Cognition Therapeutics | 81.16M |
| PolyPid | 79.57M |
| MAIA Biotechnology | 76.61M |
| Annovis Bio | 75.30M |